Mr. Nantiya Darkanon, Chief Executive Officer of Winnergy Medical Public Company Limited (WINMED) revealed that the situation of the epidemic of COVID-19 At present, the anxiety is starting to come back. due to covid-19 virus There is a mutation into a new strain that makes it easier to spread, for example, the Omicron Variant is considered a coviral-19 virus. The type 5 mutant the World Health Organization classifies as a species of concern. After the alpha, beta, gamma and delta plus strains that started spreading in Africa and some European countries If there is a widespread outbreak will make the epidemic situation worse
However, the company has adjusted its plans to cope with the risk of a new epidemic. by adjusting the service strategy – expanding the distribution channel of the comprehensive Covid-19 screening group, currently licensed for medical technology clinic establishments from the Ministry of Health Ready to provide laboratory standards for molecular verification for the genetic material of the COVID-19 virus. All species by RT-PCR and TMA (Transcription Mediated Amplification) systems, which are the only medical clinics in Thailand that have been certified for both systems. The company has received a confirmation report from the manufacturer that it can test the infection results of the coviral-19 strain B1.1.529 (Omicron Variant) together with providing proactive covid 19 screening services off-site. to be consistent with the current situation Help reduce the risk of infection of the people.
As for the products of the COVID-19 Rapid Test Kit (ATK), the company sells the JOYSBIO brand test kits for healthcare professionals. and for self-screening With a highly efficient and easy-to-use method of collecting samples from the nasopharynx. Start selling to the general public Since the end of the 3rd quarter and has also been appointed as a distributor The LITUO brand has been added to the LITUO Rapid Screening Kit for COVID-19 (ATK) for screening by means of collecting samples from the proximal nasal cavity and collecting samples from saliva. which has been approved by the Food and Drug Administration (FDA) for distribution to the general public through online channels, pharmacies, hospitals across the country Catering to the needs of a wide range of customers, both brands have been confirmed by manufacturers to be effective in testing for COVID-19. Omicron species as well
“Since there is no definite evidence that Immunity derived from currently injected vaccines can be effective in preventing the spread of Omicron strains. The company as a leader in the medical technology industry in Thailand Aware of the importance of screening for the COVID-19 virus to prevent widespread spread by providing products that are effective in detecting the COVID-19 virus All species that are currently spreading including omicron species The company uses expertise and technology that the company has, including TMA, which is a molecular test for infection. which has been used to test other viruses such as HIV, HBV, HCV and HPV for more than 10 years in Thailand and is recognized internationally We are confident that it will be able to support the increasing demand in the event of a new outbreak.” Mr Nantiya said
Mr Nantiya said
By InfoQuest News Agency (02 Dec. 64)
Tags: ATK, WINMED, Nantiya Darkanon, Winnergy Medical, Thai stocks